litlas
Log inCreate account

George Lau

Active 1994–2025

120
Papers
28,156
Citations
80
h-index
113
i10-index

Citations

Citations per year for George Lau1979: 1 citations1995: 1 citations1996: 4 citations1997: 4 citations1998: 7 citations1999: 6 citations2000: 8 citations2001: 22 citations2002: 16 citations2003: 39 citations2004: 65 citations2005: 102 citations2006: 131 citations2007: 148 citations2008: 187 citations2009: 201 citations2010: 200 citations2011: 210 citations2012: 202 citations2013: 195 citations2014: 161 citations2015: 164 citations2016: 161 citations2017: 152 citations2018: 153 citations2019: 518 citations2020: 805 citations2021: 807 citations2022: 634 citations2023: 541 citations2024: 917 citations2025: 468 citations2026: 23 citations1980–1994: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 1,747 citing papers, 15.9% of this breakdownUnited States: 1,639 citing papers, 14.9% of this breakdownUnited Kingdom: 509 citing papers, 4.6% of this breakdownGermany: 472 citing papers, 4.3% of this breakdownItaly: 469 citing papers, 4.3% of this breakdownJapan: 445 citing papers, 4.1% of this breakdownTaiwan: 428 citing papers, 3.9% of this breakdownFrance: 394 citing papers, 3.6% of this breakdownHong Kong: 380 citing papers, 3.5% of this breakdownIndia: 369 citing papers, 3.4% of this breakdownSouth Korea: 368 citing papers, 3.4% of this breakdownSpain: 319 citing papers, 2.9% of this breakdown
0%15.9%Other 31.2%

Institutions

Fields

  • Medicine85.4%
  • Biochemistry, Genetics and Molecular Biology6.3%
  • Immunology and Microbiology2.5%
  • Materials Science1.5%
  • Pharmacology, Toxicology and Pharmaceutics0.9%
  • Computer Science0.6%
  • Other2.8%

Topics

  • Hepatitis B Virus Studies12%
  • Hepatitis C virus research10.6%
  • Liver Disease Diagnosis and Treatment10.6%
  • Hepatocellular Carcinoma Treatment and Prognosis4.9%
  • Liver Disease and Transplantation4.2%
  • Hepatitis Viruses Studies and Epidemiology3%
  • Other54.7%

Coauthors

All papers

Open in search
  1. Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma

    Authors: Ghassan K. Abou‐Alfa, George Lau, Masatoshi Kudo, Stephen L. Chan, Robin Kate Kelley, Junji Furuse, Wattana Sukeepaisarnjaroen, Yoon‐Koo Kang, Tu Van Dao, Enrico N. De Toni, Lorenza Rimassa, В. В. Бредер, Alexander Vasilyev, Alexandra Heurgué, Vincent C. Tam, Kabir Mody, Satheesh Chiradoni Thungappa, Yuriy Ostapenko, Thomas Yau, Sérgio Jobim Azevedo, Marı́a Varela, Ann‐Lii Cheng, Shukui Qin, Peter R. Galle, Sajid Ali, Michelle Marcovitz, Mallory Makowsky, Philip He, John F. Kurland, Alejandra Negro, Bruno Sangro - NEJM Evidence 2022 cited by 1,432

  2. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update

    Authors: Shiv Kumar Sarin, Manoj Kumar, George Lau, Zaigham Abbas, Henry Lik‐Yuen Chan, C-J Chen, Ding‐Shinn Chen, Hsuen‐Li Chen, Pei‐Jer Chen, Rong‐Nan Chien, A. Kadir Dökmeci, Ed Gane, Jinlin Hou, Wasim Jafri, Jidong Jia, J. H. Kim, Ching‐Lung Lai, H. C. Lee, Seng Gee Lim, Chun‐Jen Liu, Stephen Locarnini, M.A. Mahtab, Rosmawati Mohamed, Masao Omata, Jeon Han Park, Teerha Piratvisuth, B. C. Sharma, Jose D. Sollano, F. S. Wang, Lai Wei, Man‐Fung Yuen, Shu Zheng, Jia‐Horng Kao - Hepatology International 2015 cited by 2,564

  3. Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

    Authors: B. Sangro, Stephen L. Chan, Robin Kate Kelley, George Lau, Masatoshi Kudo, Wattana Sukeepaisarnjaroen, M. Yarchoan, Enrico N. De Toni, J. Furuse, Yoon‐Koo Kang, Peter R. Galle, Lorenza Rimassa, Alexandra Heurgué, Vincent C. Tam, Tu Van Dao, S.C. Thungappa, В. В. Бредер, Y. Ostapenko, María Reig, M. Makowsky, Michael J. Paskow, Charu Gupta, John F. Kurland, Alejandra Negro, Ghassan K. Abou‐Alfa, Sérgio Santos de Azevêdo, Maria Ignez Braghiroli, Gustavo Girotto, Arinilda Campos Bragagnoli, Ricardo Branco, Adilson Faccio, Andrea Moretto, Nils Gunnar Skare, Jamille Dutra, Luciana Viola, Karina Vianna, Fernando Meton, Cláudia Vaz de Melo Sette, Amanda Faulhaber, Vincent C. Tam, Félix Couture, Jim Biagi, Hélène Castel, Karen Mulder, Yoo‐Joung Ko, Kevin Zbuk, Stephen Welch, Annie Beaudoin, Alexandra Heurgué, Éric Assenat, Isabelle Archambeaud, David Tougeron, Jean‐Marie Péron, Marine Gilabert, Jean–Pierre Bronowicki, Stéphane Cattan, Jean‐Frédéric Blanc, Mohamed Bouattour, Jean–Marc Phelip, Valérie Boige, Pierre Michel, Anne-Claire Frin, Enrico N. De Toni, Marie‐Luise Berres, Arndt Vogel, Thomas Berg, Thomas J. Ettrich, Dirk Waldschmidt, H. Wedemeyer, Marcus‐Alexander Wörns, Michael Bitzer, Karl-Heinz Weiss, George Lau, Stephen L. Chan, Thomas Yau, Y. Tai, Ann Shing Lee, Satheesh Chiradoni Thungappa, Lokesh K. N, Vikas Sureshchand Ostwal, Kattimani Kiran Ashok, Sushant Mittal, Hari Om Goyal, Sankar Srinivasan, Ghanashyam Biswas, Mallavarapu Mohan, Sewanti Limaye, Nirav Asarawala, Lorenza Rimassa, Alfredo Falcone, Luca Gianni, Antonio Gasbarrini, Bruno Daniele, Antonio Avallone, Giovanni Luca Frassineti, Fausto Roila, Masatoshi Kudo, Tomokazu Kawaoka, Manabu Morimoto, Yasuhiro Takikawa and 103 more - Annals of Oncology 2024 cited by 312

  4. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update

    Authors: Shiv Kumar Sarin, Ashok Choudhury, Manoj K. Sharma, Rakhi Maiwall, Mamun Al Mahtab, Salimur Rahman, Sanjiv Saigal, Neeraj Saraf, Arvinder S. Soin, Harshad Devarbhavi, Dong Joon Kim, Radhakrishan Dhiman, Ajay Duseja, Sunil Taneja, C. E. Eapen, Ashish Goel, Qin Ning, Tao Chen, Ke Ma, Zhongping Duan, Yú Chen, Sombat Treeprasertsuk, Saeed Hamid, Amna S. Butt, Wasim Jafri, Akash Shukla, Vivek A. Saraswat, Soek Siam Tan, Ajit Sood, Vandana Midha, Omesh Goyal, Hasmik Ghazinyan, Anil Arora, Jinhua Hu, Manoj Kumar Sahu, Padaki Nagaraja Rao, Guan Huei Lee, Seng Gee Lim, Laurentius A. Lesmana, Cosmas Rinaldi Adithya Lesmana, Samir Shah, V. G. Mohan Prasad, Diana A. Payawal, Zaigham Abbas, A. Kadir Dökmeci, Jose D. Sollano, Gian Carpio, Ananta Shresta, George Lau, Md. Fazal Karim, Gamal Shiha, Rino Alvani Gani, Kemal Fariz Kalista, Man‐Fung Yuen, Bikrant Bihari Lal, Rajeev Khanna, Vikrant Sood, Bikrant Bihari Lal, Viniyendra Pamecha, Ankur Jindal, V. Rajan, Vinod Arora, Osamu Yokosuka, Madunil Anuk Niriella, Hai Li, Xiaolong Qi, Atsushi Tanaka, Satoshi Mochida, Dominic Ray Chaudhuri, Ed Gane, Khin Maung Win, Wei Ting Chen, M Rela, Dharmesh Kapoor, Amit Rastogi, Pratibha Kale, Archana Rastogi, Chhagan Bihari Sharma, Meenu Bajpai, Virender Singh, Madhumita Premkumar, Sudhir Maharashi, A. Olithselvan, Cyriac Abby Philips, Anshu Srivastava, Surender Kumar Yachha, Zeeshan Ahmad Wani, B. R. Thapa, Anoop Saraya, S. Shalimar, Ashish Kumar, Manav Wadhawan, Subash Gupta, Kaushal Madan, Puja Sakhuja, Vivek Vij, Barjesh Chander Sharma, Hitendra Garg, Vishal Garg, Chetan Kalal and 12 more - Hepatology International 2019 cited by 889

  5. Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial

    Authors: Vlad Ratziu, Ladrón de Guevara, Rifaat Safadi, Fred Poordad, Felipe Fuster, Jose Flores‐Figueroa, Marco Arrese, Anna Ludovica Fracanzani, Dafna Ben Bashat, K. Lackner, Tali Gorfine, Shaul Kadosh, R. Oren, Michael Halperin, Liat Hayardeny, Rohit Loomba, Scott L. Friedman, the ARREST investigator study group, Manal F. Abdelmalek, Francesco Angelico, M. Angélico, Juan Pablo Arancibia, Edouard Bardou‐Jacquet, Francisco Barrera, Charles F. Barish, Yaacov Baruch, Ziv Ben‐Ari, Thomas Berg, Marc Bourlière, Jérôme Boursier, Efrat Broide, Michal Carmiel, Douglas Denham, L. Di Cesare, Dan L. Dumitraşcu, Adi Francis, Samer Gawrieh, María Saraí González Huezo, Patrick Hillon, A De Molina Iracheta, Zeid Kayali, Limas Kupčinskas, George Lau, Lawrence Serfaty, Aline Le Cleach, C. Loguercio, M.P. Manns, Brittany Saldivar, Edward Mena, Luis Alonso Morales-Garza, J NEUTEL, L R Nikoleishvili, Mazen Noureddin, R. Pais, Alfonso Paredes, Marcelo Paredes, Runa Watkins, Antonio Picardi, Mario Pirisi, Gonzalo Pizarro Jofré, Liliana Preoțescu, Tarek Saadi, Didier Samuel, J.F. Sánchez-Ávila, Ingolf Schiefke, Oren Shibolet, M. Shadab Siddiqui, G. Torres-Mendoza, J.F. Trotter, Eugenia Tsai, Elizabeth C. Verna, E. Zuckerman, Dinah Zur, Arun J. Sanyal - Nature Medicine 2021 cited by 215

  6. Phase 3 randomized, open-label, multicenter study of tremelimumab (T) and durvalumab (D) as first-line therapy in patients (pts) with unresectable hepatocellular carcinoma (uHCC): HIMALAYA.

    Authors: Ghassan K. Abou‐Alfa, Stephen L. Chan, Masatoshi Kudo, George Lau, Robin Kate Kelley, Junji Furuse, Wattana Sukeepaisarnjaroen, Yoon‐Koo Kang, Tu Van Dao, Enrico N. De Toni, Lorenza Rimassa, В. В. Бредер, Alexander Vasilyev, Alexandra Heurgué, Vincent C. Tam, Kabir Mody, Satheesh Chiradoni Thungappa, Philip He, Alejandra Negro, Bruno Sangro - Journal of Clinical Oncology 2022 cited by 400

  7. Spermidine and spermine delay brain aging by inducing autophagy in SAMP8 mice

    Authors: Tingting Xu, Han Li, Zhao Dai, George Lau, Benyue Li, Wenli Zhu, Xiaoqi Liu, Hao-Fei Liu, Wei-Wu Cai, Shuiqing Huang, Qi Wang, Shijie Zhang - Aging 2020 cited by 206

  8. APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy

    Authors: George Lau, Ming‐Lung Yu, Grace Lai–Hung Wong, Alexander Thompson, Hasmik Ghazinian, Jin-Lin Hou, Teerha Piratvisuth, Jidong Jia, Masashi Mizokami, Gregory Cheng, Guo-Feng Chen, Zhen-Wen Liu, Oidov Baatarkhuu, Ann‐Lii Cheng, Woon Leung Ng, Patrick Lau, Tony Mok, Jer-Ming Chang, Saeed Hamid, A. Kadir Dökmeci, Rino Alvani Gani, Diana A. Payawal, Pierce K. H. Chow, Joong‐Won Park, Simone I. Strasser, Rosmawaiti Mohamed, Khin Maung Win, Tanwandee Tawesak, Shiv Kumar Sarin, Masao Omata - Hepatology International 2021 cited by 171

  9. Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B

    Authors: George Lau, Teerha Piratvisuth, Kang Luo, Patrick Marcellin, Satawat Thongsawat, Graham Cooksley, Edward Gane, Michael Fried, Wan Cheng Chow, Seung Woon Paik, Wen Yu Chang, Thomas Berg, Robert Flisiak, Philip McCloud, N. Pluck - New England Journal of Medicine 2005 cited by 1,521

  10. Guidelines for the assessment and management of non‐alcoholic fatty liver disease in the Asia–Pacific region: Executive summary

    Authors: Geoffrey C. Farrell, Shivakumar Chitturi, George Lau, Jose D. Sollano, for the Asia–Pacific Working Party on NAFLD - Journal of Gastroenterology and Hepatology 2007 cited by 522

  11. APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis

    Authors: Hong You, Xiong Ma, Cumali Efe, Guiqiang Wang, Sook‐Hyang Jeong, Kazumichi Abe, Weijia Duan, Sha Chen, Yuanyuan Kong, Dong Zhang, Lai Wei, Fu‐Sheng Wang, Han‐Chieh Lin, Jin Mo Yang, Tawesak Tanwandee, Rino Alvani Gani, Diana A. Payawal, Barjesh Chander Sharma, Jinlin Hou, Osamu Yokosuka, A. Kadir Dökmeci, Dorothy H. Crawford, Jia‐Horng Kao, Teerha Piratvisuth, Dong Jin Suh, Laurentius A. Lesmana, Jose D. Sollano, George Lau, Shiv Kumar Sarin, Masao Omata, Atsushi Tanaka, Jidong Jia - Hepatology International 2022 cited by 123

  12. Drug-Induced Acute-on-Chronic Liver Failure in Asian Patients

    Authors: Harshad Devarbhavi, Ashok Choudhury, Manoj Kumar Sharma, Rakhi Maiwall, Mamun Al Mahtab, Salimur Rahman, Yogesh Chawla, Radha K. Dhiman, Ajay Duseja, Sunil Taneja, Qin Ning, Ji Dong Jia, Zhongping Duan, Yú Chen, C. E. Eapen, Ashish Goel, Soek Siam Tan, Saeed Hamid, Amna Subhan Butt, Wasim Jafri, Dong Joon Kim, Jinhua Hu, Ajit Sood, Vandana Midha, Akash Shukla, Hasmik Ghazinian, Manoj Kumar Sahu, Sombat Treeprasertsuk, Guan Huei Lee, Seng Gee Lim, L.A. Lesmana, Cosmas Rinaldi Adithya Lesmana, Samir Shah, Chetan Kalal, Zaigham Abbas, Jose D. Sollano, V. G. Mohan Prasad, Diana Payawal, A. Kadir Dökmeci, Padaki Nagaraja Rao, Ananta Shrestha, George Lau, Man‐Fung Yuen, Vivek A. Saraswat, Gamal Shiha, Osamu Yokosuka, Chandan Kumar Kedarisetty, Priyanka Jain, P. Bhatia, Shiv Kumar Sarin, for the APASL ACLF working party - The American Journal of Gastroenterology 2019 cited by 83

  13. Liver failure determines the outcome in patients of acute-on-chronic liver failure (ACLF): comparison of APASL ACLF research consortium (AARC) and CLIF-SOFA models

    Authors: APASL ACLF Working Party, Ashok Choudhury, Ankur Jindal, Rakhi Maiwall, M. K. Sharma, B. C. Sharma, Viniyendra Pamecha, M.A. Mahtab, S Rahman, Yogesh Chawla, Sunil Taneja, S. S. Tan, Harshad Devarbhavi, Zhongping Duan, Yú Chen, Qin Ning, Ji Dong Jia, Deepak Amarapurkar, C. E. Eapen, Ashish Goel, Saeed Hamid, Amna Subhan Butt, Wasim Jafri, D. J. Kim, Hasmik Ghazinian, Guan Huei Lee, Ajit Sood, Laurentius A. Lesmana, Zaigham Abbas, Gamal Shiha, Diana A. Payawal, A. Kadir Dökmeci, Jose D. Sollano, Gian Carpio, George Lau, Fazal Karim, Padaki Nagaraja Rao, Richard Moreau, Pratik Jain, P. Bhatia, G. Kumar, Shiv Kumar Sarin - Hepatology International 2017 cited by 220

  14. Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy1 ☆

    Authors: Bettina Werle–Lapostolle, Scott Bowden, Stephen Locarnini, Karsten Wursthorn, Jörg Petersen, George Lau, Christian Trépo, Patrick Marcellin, Zachary Goodman, William E. Delaney - Gastroenterology 2004 cited by 899

  15. A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease

    Authors: Huai Zhang, Giovanni Targher, Christopher D. Byrne, Seung Up Kim, Vincent Wai-Sun Wong, Luca Valenti, Myer Glickman, Jaime Ponce, Christos S. Mantzoros, Javier Crespo, Henning Grønbæk, Wah Yang, Mohammed Eslam, Robert J. Wong, Mariana Verdelho Machado, Ming-Lung Yu, Omar M. Ghanem, Takeshi Okanoue, Junfeng Liu, Yong‐ho Lee, Xiao-Yuan Xu, Qiuwei Pan, Meili Sui, Amedeo Lonardo, Yusuf Yılmaz, Li-Yong Zhu, Christophe Moreno, Luca Miele, Monica Lupșor‐Platon, Lei Zhao, Teresa LaMasters, Robert G. Gish, Huijie Zhang, Marius Nedelcu, Wah‐Kheong Chan, Mingfeng Xia, Fernando Bril, Junping Shi, Christian Datz, Stefano Romeo, Jian Sun, Dan Liu, Silvia Sookoian, Yimin Mao, Nahum Méndez-Sánchez, Xiaoyan Wang, Nikolaos T. Pyrsopoulos, Jian‐Gao Fan, Yasser Fouad, Dan-Qin Sun, Cosimo Giannini, Jin Chai, Ze-Feng Xia, Dae Won Jun, Guojing Li, Sombat Treeprasertsuk, Ying-Xu Li, Tan To Cheung, Faming Zhang, George Boon‐Bee Goh, Masato Furuhashi, Wai‐Kay Seto, Hui Huang, Anna Di Sessa, Qing-Hong Li, Evangelos Cholongitas, Le Zhang, Themis Reverbel da Silveira, Giada Sebastiani, Leon A. Adams, Wei Chen, Xiaolong Qi, Ivan Ranković, Victor de Lédinghen, Wenjie Lv, Masahide Hamaguchi, Radwan Kassir, Dirk Müller‐Wieland, Manuel Romero‐Gómez, Ying Xu, Yicong Xu, Shiyao Chen, Mohammad Kermansaravi, Mohammad Shafi Kuchay, Sander Lefere, Chetan Parmar, Gregory Y.H. Lip, Chun‐Jen Liu, Fredrik Åberg, George Lau, Jacob George, Shiv Kumar Sarin, Jing-Ya Zhou, Ming‐Hua Zheng, on behalf of the MAFLD ICD-11 coding collaborators, Huai Zhang, Giovanni Targher, Christopher D. Byrne, Seung Up Kim, Vincent Wai-Sun Wong and 874 more - Hepatology International 2024 cited by 33

  16. COVID-19: Discovery, diagnostics and drug development

    Authors: Tarik Asselah, David Durantel, Éric Pasmant, George Lau, Raymond F. Schinazi - Journal of Hepatology 2020 cited by 453

  17. The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease

    Authors: Mohammed Eslam, Jian‐Gao Fan, Ming‐Lung Yu, Vincent Wai‐Sun Wong, Ian Homer, Chun‐Jen Liu, Tawesak Tanwandee, Rino Alvani Gani, Wai‐Kay Seto, Shahinul Alam, Dan Yock Young, Saeed Hamid, Ming‐Hua Zheng, Takumi Kawaguchi, Wah‐Kheong Chan, Diana Payawal, Soek-Siam Tan, George Boon‐Bee Goh, Simone I. Strasser, Hang Viet Dao, Jia‐Horng Kao, Won Kim, Seung Up Kim, Shelley E. Keating, Yusuf Yılmaz, Lubna Kamani, Chia‐Chi Wang, Yasser Fouad, Zaigham Abbas, Sombat Treeprasertsuk, Kessarin Thanapirom, Mamun Al Mahtab, Undram Lkhagvaa, Oidov Baatarkhuu, Ashok Choudhury, Catherine A. Stedman, Abhijit Chowdhury, A. Kadir Dökmeci, Fu‐Sheng Wang, Han‐Chieh Lin, Jee‐Fu Huang, Jess Howell, Jidong Jia, Mohamed Alboraie, Stuart K. Roberts, Masato Yoneda, Hasmik Ghazinian, Aram Mirijanyan, Yuemin Nan, Cosmas Rinaldi Adithya Lesmana, Leon A. Adams, Gamal Shiha, Manoj Kumar, Necati Örmecı, Lai Wei, George Lau, Masao Omata, Shiv Kumar Sarin, Jacob George - Hepatology International 2025 cited by 127

  18. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL)

    Authors: Shiv Kumar Sarin, Ashish Kumar, John Almeida, Yogesh Chawla, Sheung Tat Fan, Hitendra Garg, H Janaka de Silva, Saeed Hamid, Rajiv Jalan, Piyawat Komolmit, George Lau, Qing Liu, Kaushal Madan, Rosmawati Mohamed, Qin Ning, Salimur Rahman, Archana Rastogi, Stephen M. Riordan, Puja Sakhuja, Didier Samuel, Samir Shah, Barjesh Chander Sharma, Praveen Sharma, Yasuhiro Takikawa, Babu Ram Thapa, Chun‐Tao Wai, Man‐Fung Yuen - Hepatology International 2008 cited by 762

  19. Natural history and disease progression in Chinese chronic hepatitis B patients in immune‐tolerant phase†

    Authors: Chee‐Kin Hui, Nancy Leung, Siu–Tsan Yuen, Haiying Zhang, Kar‐Wai Leung, Lei Lu, Stephen K. F. Cheung, Wai‐Man Wong, George Lau - Hepatology 2007 cited by 272

  20. Five-year overall survival update from the HIMALAYA study of tremelimumab plus durvalumab in unresectable HCC

    Authors: Lorenza Rimassa, Stephen L. Chan, Bruno Sangro, George Lau, Masatoshi Kudo, María Reig, В. В. Бредер, Min‐Hee Ryu, Yuriy Ostapenko, Wattana Sukeepaisarnjaroen, Marı́a Varela, David Tougeron, Oxana Crysler, Mohamed Bouattour, Tu Van Dao, Vincent C. Tam, Adilson Faccio, Junji Furuse, Long-Bin Jeng, Yoon‐Koo Kang, Robin Kate Kelley, Michael J. Paskow, Di Ran, Ioannis Xynos, John F. Kurland, Alejandra Negro, Ghassan K. Abou‐Alfa - Journal of Hepatology 2025 cited by 109

  21. Impairment of CD4+ cytotoxic T cells predicts poor survival and high recurrence rates in patients with hepatocellular carcinoma

    Authors: Junliang Fu, Zheng Zhang, Lin Zhou, Zhaorui Qi, Shaojun Xing, Jiyun Lv, Jianfei Shi, Baoyun Fu, Zhenwen Liu, Ji‐Yuan Zhang, Lei Jin, Yulai Zhao, George Lau, Jingmin Zhao, Fu‐Sheng Wang - Hepatology 2012 cited by 205

  22. SO-15 Four-year overall survival update from the phase 3 HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

    Authors: Bruno Sangro, Stephen L. Chan, Robin Kate Kelley, George Lau, Masatoshi Kudo, Wattana Sukeepaisarnjaroen, Enrico de Toni, Junji Furuse, Yoon‐Koo Kang, Peter R. Galle, Lorenza Rimassa, Alexandra Heurgué, Vincent C. Tam, Thông Dao, Satheesh Chiradoni Thungappa, В. В. Бредер, Y. Ostapenko, María Reig, M. Makowsky, Charu Gupta, Alejandra Negro, Ghassan K. Abou‐Alfa - Annals of Oncology 2023 cited by 21

  23. Peginterferon Alfa-2a Alone, Lamivudine Alone, and the Two in Combination in Patients with HBeAg-Negative Chronic Hepatitis B

    Authors: Patrick Marcellin, George Lau, Ferruccio Bonino, Patrizia Farci, Stephanos J. Hadziyannis, Rui Jin, Zhi‐Meng Lu, Teerha Piratvisuth, Georgios Germanidis, Cihan Yurdaydın, M. Diago, Selım Gürel, Ming‐Yang Lai, Peter Button, N. Pluck - New England Journal of Medicine 2004 cited by 1,141

  24. Silver Nanoparticles Inhibit Hepatitis B virus Replication

    Authors: Lei Lu, Raymond Wai‐Yin Sun, Rong Chen, Chee‐Kin Hui, Chi‐Ming Ho, John M. Luk, George Lau, Chi‐Ming Che - Antiviral Therapy 2008 cited by 600